124 related articles for article (PubMed ID: 22048966)
1. Diagnosis of endocrine disease: limitations of the IGF1 generation test in children with short stature.
Coutant R; Dörr HG; Gleeson H; Argente J
Eur J Endocrinol; 2012 Mar; 166(3):351-7. PubMed ID: 22048966
[TBL] [Abstract][Full Text] [Related]
2. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
Blair JC; Camacho-Hübner C; Miraki Moud F; Rosberg S; Burren C; Lim S; Clayton PE; Bjarnason R; Albertsson-Wikland K; Savage MO
Clin Endocrinol (Oxf); 2004 Feb; 60(2):163-8; discussion 161-2. PubMed ID: 14725676
[TBL] [Abstract][Full Text] [Related]
3. Statement 3: a low serum IGF-I Level in idiopathic short stature patients indicates partial GH insensitivity.
Bang P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():841-6. PubMed ID: 18438327
[No Abstract] [Full Text] [Related]
4. IGFs and IGFBPs in GH insensitivity.
Savage MO; Blair JC; Jorge AJ; Street ME; Ranke MB; Camacho-Hübner C
Endocr Dev; 2005; 9():100-106. PubMed ID: 15879692
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation.
Storr HL; Dunkel L; Kowalczyk J; Savage MO; Metherell LA
Eur J Endocrinol; 2015 Feb; 172(2):151-61. PubMed ID: 25411237
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor I generation test in the investigation of short stature.
Cotterill AM; Camacho-Hübner C; Woods K; Martinelli C; Duquesnoy P; Savage MO
Acta Paediatr Suppl; 1994 Apr; 399():128-30. PubMed ID: 7949597
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of disorders of IGF-I synthesis and action.
Wit JM
Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():538-40. PubMed ID: 22423513
[TBL] [Abstract][Full Text] [Related]
9. Effects of GH/IGF-I Axis on Retinal Vascular Morphology: Retinal Vascular Characteristics in a Clinical Setting with Severe IGF-I Deficiency.
Sekeroglu HT; Kadayıfcılar S; Kasım B; Arslan U; Ozon A
Ophthalmic Genet; 2016; 37(1):53-8. PubMed ID: 25078475
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
[TBL] [Abstract][Full Text] [Related]
11. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI).
Ramírez L; Sanguineti N; Scaglia P; Keselman A; Ballerini MG; Karabatas L; Landi E; Castro J; Domené S; Pennisi P; Jasper H; Rey RA; Vázquez M; Domené H; Bergadá I; Gutiérrez M
Growth Horm IGF Res; 2020 Feb; 50():61-70. PubMed ID: 31902742
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
15. [Short stature investigation: clinical, laboratorial and genetic aspects concerning the growth hormone insensitivity (GHI)].
Jorge AA
Arq Bras Endocrinol Metabol; 2008 Aug; 52(6):1056-65. PubMed ID: 18820818
[TBL] [Abstract][Full Text] [Related]
16. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
Hardin DS; Woo J; Butsch R; Huett B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity.
David A; Hwa V; Metherell LA; Netchine I; Camacho-Hübner C; Clark AJ; Rosenfeld RG; Savage MO
Endocr Rev; 2011 Aug; 32(4):472-97. PubMed ID: 21525302
[TBL] [Abstract][Full Text] [Related]
18. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.
Cohen P; Rogol AD; Deal CL; Saenger P; Reiter EO; Ross JL; Chernausek SD; Savage MO; Wit JM;
J Clin Endocrinol Metab; 2008 Nov; 93(11):4210-7. PubMed ID: 18782877
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of growth disorders in the paediatric clinic.
Cappa M; Loche S
J Endocrinol Invest; 2003; 26(7 Suppl):54-63. PubMed ID: 14604067
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
